The perinucleolar compartment: structure, function, and utility in anti-cancer drug development

Eugene V. MakeyevSui Huanga Centre for Developmental Neurobiology,King's College London,London,UKb Department of Cell and Developmental Biology,Northwestern University,Chicago,IL,USA
DOI: https://doi.org/10.1080/19491034.2024.2306777
2024-01-28
Nucleus
Abstract:The perinucleolar compartment (PNC) was initially identified as a nuclear structure enriched for the polypyrimidine tract-binding protein. Since then, the PNC has been implicated in carcinogenesis. The prevalence of this compartment is positively correlated with disease progression in various types of cancer, and its expression in primary tumors is linked to worse patient outcomes. Using the PNC as a surrogate marker for anti-cancer drug efficacy has led to the development of a clinical candidate for anti-metastasis therapies. The PNC is a multicomponent nuclear body situated at the periphery of the nucleolus. Thus far, several non-coding RNAs and RNA-binding proteins have been identified as the PNC components. Here, we summarize the current understanding of the structure and function of the PNC, as well as its recurrent links to cancer progression and metastasis.
cell biology
What problem does this paper attempt to address?